Related Experiment Video
Updated: Aug 6, 2026

Evaluating Cell Death Using Cell-Free Supernatant of Probiotics in Three-Dimensional Spheroid Cultures of Colorectal Cancer Cells
Published on: June 13, 2020
Modulating the head & neck microbiome for cancer- prevention
Sherin James1, Akhilesh M Wodeyar2, Akhilanand Chaurasia3
1Department of Otolaryngology, University of Alabama at Birmingham, United States.
Modulating the head and neck microbiome offers a promising strategy for head and neck cancer (HNC) prevention and treatment. Interventions like diet and probiotics aim to restore microbial balance, reduce inflammation, and boost anti-cancer immunity.
Area of Science:
- Microbiome research
- Oncology
- Immunology
Background:
- The head and neck microbiome is crucial for epithelial homeostasis and immune surveillance.
- Microbial dysbiosis in oral and gut ecosystems is linked to head and neck cancer (HNC) initiation and progression.
- The microbiome is a modifiable risk factor in HNC.
Purpose of the Study:
- To review current knowledge on microbiome-based interventions for HNC.
- To emphasize the immunomodulatory and anti-inflammatory effects of these interventions.
- To discuss challenges and future directions in microbiome modulation for HNC.
Main Methods:
- Review of current literature on microbiome-based interventions.
- Analysis of dietary modification, probiotics, prebiotics, postbiotics, synbiotics, fecal microbiota transplantation, and lifestyle changes.
- Exploration of mechanistic links between microbial metabolites, immune pathways, and the oral-gut axis.
Main Results:
- Microbiome modulation strategies aim to restore microbial balance, enhance barrier integrity, and reduce chronic inflammation.
- These interventions can strengthen anticancer immune responses.
- Emerging evidence connects microbiome composition with treatment response and toxicity in HNC.
Conclusions:
- Microbiome modulation is a promising, precision-oriented strategy for HNC prevention, risk reduction, and survivorship.
- Further research is needed to address inter-individual variability, site-specific niches, and safety.
- Robust clinical validation is required for widespread application.
Related Concept Videos
Microbiota Modulation by Antibiotics
Introduction to the Human Microbiota
Development of Human Microbiota
The Oral Microbiota
What is Monogastric Digestion?
Gut-Brain Axis
